Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
MOTS-c is a naturally occurring mitochondrial-derived peptide that plays a role in regulating metabolism, insulin sensitivity, cellular energy production, and exercise adaptation. It functions as a metabolic signaling molecule, helping cells respond to energy stress and promoting improved glucose utilization and fat metabolism. MOTS-c has gained significant interest for its potential effects on metabolic health, body composition, exercise performance, and healthy aging.
Common Research Dosing Protocol:
5-15 mg administered 2-3 times per week
Common protocol: 10 mg three times weekly
Alternative protocol: 15 mg every other day
Typical cycle length: 4-12 weeks
Administration:
Subcutaneous injection
Often administered in the morning
Some protocols time administration before exercise to support training adaptations
Storage:
Refrigerate at 36-46°F (2-8°C) after reconstitution
Protect from light
Do not freeze
Use sterile technique for all withdrawals
Notes:
MOTS-c is frequently researched for:
Improved insulin sensitivity
Enhanced glucose disposal
Increased metabolic flexibility
Fat loss support
Exercise endurance and recovery
Healthy aging and mitochondrial function
It is commonly stacked with AICAR, SS-31, Retatrutide, or Tesamorelin in metabolic optimization protocols. Many researchers view MOTS-c as one of the more promising mitochondrial peptides because it appears to influence both energy production and metabolic signaling pathways. Benefits are often reported gradually over several weeks, particularly when combined with regular exercise and appropriate nutrition.
MOTS-c is a naturally occurring mitochondrial-derived peptide that plays a role in regulating metabolism, insulin sensitivity, cellular energy production, and exercise adaptation. It functions as a metabolic signaling molecule, helping cells respond to energy stress and promoting improved glucose utilization and fat metabolism. MOTS-c has gained significant interest for its potential effects on metabolic health, body composition, exercise performance, and healthy aging.
Common Research Dosing Protocol:
5-15 mg administered 2-3 times per week
Common protocol: 10 mg three times weekly
Alternative protocol: 15 mg every other day
Typical cycle length: 4-12 weeks
Administration:
Subcutaneous injection
Often administered in the morning
Some protocols time administration before exercise to support training adaptations
Storage:
Refrigerate at 36-46°F (2-8°C) after reconstitution
Protect from light
Do not freeze
Use sterile technique for all withdrawals
Notes:
MOTS-c is frequently researched for:
Improved insulin sensitivity
Enhanced glucose disposal
Increased metabolic flexibility
Fat loss support
Exercise endurance and recovery
Healthy aging and mitochondrial function
It is commonly stacked with AICAR, SS-31, Retatrutide, or Tesamorelin in metabolic optimization protocols. Many researchers view MOTS-c as one of the more promising mitochondrial peptides because it appears to influence both energy production and metabolic signaling pathways. Benefits are often reported gradually over several weeks, particularly when combined with regular exercise and appropriate nutrition.